v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Ordinary Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balances at Dec. 31, 2024   $ 1,141,060 $ 7 $ (965,522) $ 175,545
Balances (in shares) at Dec. 31, 2024 49,471,000        
Increase (Decrease) in Stockholders' Equity          
Proceeds from the sale of ordinary shares   20     20
Proceeds from the sale of ordinary shares (in shares) 2,000        
Employee share-based compensation expense   4,877     4,877
Issuance of restricted shares $ 1       1
Issuance of restricted shares (in shares) 619,000        
Repurchase of shares to satisfy tax withholding   (874)     (874)
Repurchase of shares to satisfy tax withholding (in shares) (91,000)        
Net unrealized loss on marketable securities     (7)   (7)
Net loss       (13,579) (13,579)
Balances at Mar. 31, 2025 $ 1 1,145,083   (979,101) 165,983
Balances (in shares) at Mar. 31, 2025 50,001,000        
Balances at Dec. 31, 2025 $ 1 1,156,288 61 (859,627) $ 296,723
Balances (in shares) at Dec. 31, 2025 51,069,000       51,069,000
Increase (Decrease) in Stockholders' Equity          
Employee share-based compensation expense   4,504     $ 4,504
Issuance of restricted shares (in shares) 720,000        
Option exercises   241     $ 241
Option exercises (in shares) 22,000       22,044
Repurchase of shares to satisfy tax withholding   (5,818)     $ (5,818)
Repurchase of shares to satisfy tax withholding (in shares) (296,000)        
Net unrealized loss on marketable securities     (123)   (123)
Net loss       (4,933) (4,933)
Balances at Mar. 31, 2026 $ 1 $ 1,155,215 $ (62) $ (864,560) $ 290,594
Balances (in shares) at Mar. 31, 2026 51,515,000       51,515,000